The trajectory of companies tied to the drug's past presents a challenging investment landscape. While the initial boom generated substantial returns , generic competition have significantly eroded revenue. https://mirrorbookmarks.com/story21536752/copyright-s-flagship-product-and-the-pharmaceutical-sector-a-uncertain-venture